查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1995358

醫療設備測試市場：依服務類型、器材類型、器材類別、測試階段、採購模式、測試方法和最終用戶分類－2026年至2032年全球市場預測

Medical Device Testing Market by Service Type, Device Type, Device Class, Test Phase, Sourcing Model, Testing Method, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，醫療設備測試市場價值將達到 126.4 億美元，到 2026 年將成長至 136.9 億美元，到 2032 年將達到 227.5 億美元，複合年成長率為 8.75%。

主要市場統計數據
基準年 2025 126.4億美元
預計年份：2026年 136.9億美元
預測年份 2032 227.5億美元
複合年成長率 (%) 8.75%

在技​​術日益複雜、監管日益嚴格以及商業性需求日益迫切的背景下，了解現代醫療設備測試環境對於策略決策至關重要

醫療設備的測試環境正處於一個十字路口，科學嚴謹性、監管要求和商業性緊迫性在此交匯。近年來，材料科學、數位診斷和流程自動化的進步不斷提高臨床前和臨床檢驗的技術難度。因此，品質保證團隊和測試實驗室面臨巨大的壓力，需要在日益複雜的醫療設備架構中提供更詳細的表徵、更快的交付速度和可驗證的可追溯性。這種環境要求我們在測試優先順序、產能規劃以及研發、監管和生產等相關人員之間的跨部門合作方面採取新的觀點。

分析技術的進步、監管生命週期的期望以及商業性壓力如何共同重新定義檢查室能力、夥伴關係和檢驗方法。

近年來，醫療設備測試的設計、實施和結果解讀方式發生了翻天覆地的變化。高解析度質譜和新一代顯微鏡等分析儀器的進步，使得數據更加豐富，從而能夠更深入地了解材料與醫療設備之間的相互作用機制。同時，樣品處理和檢查室資訊管理系統的自動化提高了測試的可重複性，縮短了測試週期，並支援了迭代式設計檢驗循環，加快了監管申報流程。

了解美國關稅變化對營運、財務和監管方面的多方面影響，以及這些變化將如何重組您的測試採購、供應商選擇和合規策略。

關稅的徵收和貿易政策的變化對醫療設備檢測生態系統的影響是漸進式和累積的，遠不止成本增加那麼簡單。進口原料、設備或耗材的關稅會改變籌資策略，並進一步增加關鍵試劑和組件前置作業時間的不確定性。因此，實驗室管理人員和採購團隊應考慮雙重採購策略和區域庫存緩衝，以便將關稅相關的延誤納入檢驗計劃，維持檢測能力，並按時完成監管申報。

透過對測試類型、技術、最終用戶和醫療設備分類進行多層細分，可以確定實驗室能力要求和驗證途徑的選擇。

細分方式的細微差別會對測試優先順序和資源分配產生重大影響。此外，深入了解測試類型、技術、最終用戶和醫療設備分類有助於更精細地設計測試方案。在考慮測試類型時，生物相容性是一項基本要求。這包括細胞毒性測試、刺激性和致敏性評估以及藥物動力學評估，這些測試共同決定了材料與宿主之間的相互作用。化學分析透過對萃取物和洗脫液的特性來補充生物學測試，而電氣安全性、機械性能測試、性能評估和滅菌驗證則各自提供一系列必要的證據，以確保醫療設備的安全有效運作。滅菌驗證本身需要針對每種滅菌方法進行方法特異性驗證，例如乾熱滅菌、環氧乙烷滅菌、輻射滅菌和蒸氣，而方法的選擇取決於醫療設備的材料和預期用途。

我們制定驗證策略，透過克服區域間不同的監管要求、實驗室能力和供應鏈實際情況，最佳化進入全球市場的途徑。

區域趨勢造就了獨特的需求特徵、監管要求和營運限制，這些都必須在測試策略中加以考慮。在美洲，成熟的法規結構以及醫療設備製造商的高度集中，推動了對全面的上市前測試和上市後監測能力的需求。該地區的實驗室通常優先考慮快速提交監管申請並與臨床試驗計劃相銜接；而從供應鏈的角度來看，短期庫存管理和靈活的服務模式對於滿足緊湊的市場週期至關重要。

差異化的測試能力、策略夥伴關係和服務整合如何決定競爭優勢並塑造合作夥伴選擇標準。

企業行為和競爭定位影響著檢測能力的拓展方向和方式，各公司透過能力深度、地理覆蓋範圍和綜合服務產品來脫穎而出。頂尖的分析服務供應商通常強調端到端的服務組合，整合化學表徵、生物評估和滅菌方面的專業知識，以支援各種應用。這些提供者投資於高通量儀器、檢驗的工作流程和品管系統，以吸引尋求單一供應商責任制的大型製造商。

透過設計測試策略、與監管機構合作以及將其與強大的採購系統相結合，加快合規產品開發和市場准入的實用方法。

行業領導企業應採取積極主動的方式，將測試策略與產品開發、監管溝通和供應鏈韌性相結合。這首先應應用基於風險的框架，優先考慮對臨床性能和監管核准影響最大的檢測方法，並在產品設計過程的早期階段就納入測試方面的考慮。早期協調可以減少後期不可預見事件的發生，使工程和驗證活動能夠並行開展，並最終縮短整體研發週期。

採用嚴謹且多方面的研究途徑，結合專家訪談、技術檢驗和情境分析，為檢驗策略和操作提供可靠的見解。

本分析所依據的研究結合了結構化的一手研究和系統的二手調查，並輔以技術檢驗，以確保得出切實可行的見解。一手研究包括對監管專家、高級檢查室管理人員、品質保證負責人和臨床實踐專家的訪談，以獲取關於產能限制、檢測方法開發重點和監管合作的第一手觀點。這些訪談提供了有關實際營運情況的背景信息，例如前置作業時間、認證挑戰和投資權衡。

綜合結論表明，有必要將測試定位為核心能力，並使驗證與監管、技術和商業性現實保持一致。

總之，醫療設備測試領域正因技術進步、監管要求不斷提高以及商業性壓力變化而迅速發展。成功的企業將測試定位為一項策略能力，投資於合適的技術和夥伴關係關係，並設計能夠預見整個生命週期證據需求的驗證路徑。關稅變化和區域趨勢進一步加劇了商業環境的複雜性，凸顯了靈活籌資策略和監管協調對於減少跨境摩擦的必要性。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：醫療設備檢測市場：依服務類型分類

  • 生物相容性測試
  • 機械和物理測試
  • 電氣安全和電磁相容性
  • 無菌和微生物檢測
  • 包裝和保存期限測試
  • 軟體和網路安全測試
  • 臨床性能和安全性測試
  • 化學表徵和材料分析

第9章：醫療設備檢測市場：依器材類型分類

  • 體外診斷醫療設備
  • 主動式植入式醫療設備
  • 非活性植入式醫療設備
  • 手術器械和工具
  • 醫療影像設備
  • 病患監測設備
  • 穿戴式裝置和家用設備
  • 藥品和醫療設備組合產品
  • 牙科醫療設備
  • 整形外科醫療設備
  • 眼科醫療設備

第10章：醫療設備檢測市場－依醫療設備類別分類

  • I類醫療設備
  • Ⅱ類醫療設備
  • III類醫療設備
  • 體外診斷醫療設備的風險等級

第11章醫療設備測試市場（依測試階段分類）

  • 概念和可行性
  • 設計檢驗和確認
  • 臨床前試驗
  • 臨床試驗
  • 上市後監測和再檢驗

第12章：醫療設備偵測市場（依採購模式分類）

  • 公司內部測試
  • 外包測試
  • 混合測試模型

第13章 依測試方法分類的醫療設備測試市場

  • 體外方法
  • 體內試驗方法

第14章醫療設備測試市場：依最終用戶分類

  • 醫療設備製造商
  • 受委託的研究機構
  • 獨立測試機構
  • 醫院和診所
  • 學術和研究機構

第15章：醫療設備檢測市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第16章醫療設備檢測市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第17章醫療設備檢測市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第18章：美國醫療設備檢測市場

第19章：中國醫療設備檢測市場

第20章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • BSI Group UK Limited
  • Bureau Veritas SA
  • Charles River Laboratories International, Inc.
  • CSA Group
  • DEKRA SE
  • Eurofins Scientific SE
  • GE HealthCare Technologies Inc.
  • Intertek Group plc
  • Labcorp Holdings Inc.
  • NSF International
  • Societe Generale de Surveillance SA
  • Thermo Fisher Scientific Inc.
  • TUV SUD AG
  • UL LLC
  • WuXi AppTec Co., Ltd.
Product Code: MRR-6611A5111648

The Medical Device Testing Market was valued at USD 12.64 billion in 2025 and is projected to grow to USD 13.69 billion in 2026, with a CAGR of 8.75%, reaching USD 22.75 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 12.64 billion
Estimated Year [2026] USD 13.69 billion
Forecast Year [2032] USD 22.75 billion
CAGR (%) 8.75%

Framing the modern medical device testing environment amid escalating technical complexity, regulatory scrutiny, and commercial urgency to inform strategic decisions

The medical device testing landscape sits at a crossroads where scientific rigor, regulatory scrutiny, and commercial urgency converge. In recent years, advances in materials science, digital diagnostics, and process automation have steadily elevated the technical bar for preclinical and clinical validation. Consequently, quality assurance teams and testing laboratories are under pressure to deliver deeper characterization, faster turnaround, and demonstrable traceability across increasingly complex device architectures. This dynamic requires a fresh view of testing priorities, capacity planning, and cross-functional coordination across R&D, regulatory, and manufacturing stakeholders.

As stakeholders confront compressed development cycles and heightened safety expectations, the role of testing expands beyond binary pass/fail determinations to encompass risk-based evidence generation, lifecycle surveillance strategies, and post-market vigilance integration. Regulatory authorities worldwide emphasize robust scientific justification, iterative validation, and transparent data governance, which in turn intensify the need for comprehensive testing strategies that bridge bench science with clinical performance. Understanding these pressures is essential for leaders who must balance cost control with the imperative to de-risk product performance and accelerate time to patient impact.

This introduction frames the rest of the analysis by highlighting how technical complexity, regulatory evolution, and commercial imperatives interact to shape testing investments and operational design. It sets the stage for a deeper examination of transformative shifts, tariff-related headwinds, segmentation-specific insights, regional dynamics, competitive behaviors, practical recommendations, and the research approach underpinning these conclusions.

How analytical advances, regulatory lifecycle expectations, and commercial pressure are jointly redefining laboratory capabilities, partnerships, and validation approaches

The past several years have produced transformative shifts that reshape how device testing is designed, executed, and interpreted. Advances in analytical instrumentation such as high-resolution mass spectrometry and next-generation microscopy provide richer datasets, thereby enabling more mechanistic insights into material-device interactions. At the same time, automation in sample handling and laboratory information management systems improves reproducibility and compresses cycle times, which supports iterative design-validation loops and faster regulatory submissions.

In parallel, regulatory frameworks have evolved to emphasize lifecycle evidence and real-world performance, extending testing obligations beyond initial clearance to include post-market surveillance and periodic re-evaluation. This change compels organizations to architect testing strategies that are adaptive and longitudinal. Moreover, the proliferation of combination products, software-enabled devices, and advanced materials introduces multidisciplinary testing requirements that demand cross-disciplinary laboratory capabilities and collaborative partnerships between manufacturers and third-party laboratories.

Commercial dynamics also drive transformation. Cost pressures and the need for supply chain resilience accelerate investment in onshore and regional testing capacity, while strategic outsourcing models increasingly favor specialized contract labs capable of integrated analytical and biological assessments. Consequently, testing has become a strategic enabler rather than a back-office function, directly influencing go-to-market timing, reimbursement discussions, and acceptance by clinical stakeholders.

Understanding the multifaceted operational, financial, and regulatory consequences of U.S. tariff changes and how they reshape testing procurement, sourcing, and compliance strategies

The imposition of tariffs and changes in trade policy introduce discrete and cumulative effects on the device testing ecosystem that extend beyond simple cost increases. Tariffs on imported raw materials, instrumentation, or consumables can alter procurement strategies and foster greater variability in lead times for critical reagents and components. Laboratory managers and procurement teams must therefore incorporate duty-related delays into validation timelines and consider dual-sourcing strategies or regional inventory buffers to preserve testing throughput and meet regulatory submission windows.

Tariff-driven cost inflation often cascades through the supply chain, prompting manufacturers to assess whether to absorb increased testing costs, pass them to customers, or restructure product bill of materials to mitigate exposure. These decisions have downstream implications for testing volumes and the demand profile for specialized assays. In addition, tariff-related uncertainty can accelerate conversations about reshoring or nearshoring of both manufacturing and testing services to stabilize supply and reduce exposure to cross-border policy shifts. Such shifts require capital investment, workforce development, and reciprocal adaptation by accreditation bodies and regulatory authorities that oversee laboratory operations.

Finally, tariffs interact with regulatory compliance in nuanced ways. When testing components or services move across borders to avoid tariffs, manufacturers must ensure equivalency in testing standards, documentation, and traceability. Achieving regulatory alignment across jurisdictions adds complexity and can lengthen approval pathways unless proactively managed through harmonized protocols and early engagement with assessors. In short, tariffs in 2025 are not merely a financial issue; they shape operational design, strategic sourcing, and the architecture of compliance across the testing continuum.

How layered segmentation across test types, technologies, end users, and device classifications determines laboratory capability requirements and validation pathway choices

Segmentation nuances materially influence testing priorities and resource allocation, and a granular understanding of test types, technologies, end users, and device classifications enables more precise program design. When examining test types, biocompatibility emerges as a foundational requirement, encompassing cytotoxicity assays, irritation and sensitization evaluations, and toxicokinetic assessments that together determine material-host interactions. Chemical analysis complements biological testing by characterizing extractables and leachables, while electrical safety, mechanical testing, performance assessment, and sterilization validation each contribute discrete evidence streams required for safe, effective device operation. Sterilization validation itself requires method-specific validation across dry heat, ethylene oxide, radiation, and steam modalities, with method selection shaped by device materials and intended use.

Technology segmentation further refines laboratory requirements. Chromatography techniques, including gas chromatography, high-performance liquid chromatography, and ion chromatography, provide quantitative specificity for small-molecule profiling and impurity characterization. Spectroscopic techniques such as Fourier-transform infrared analysis, mass spectrometry, nuclear magnetic resonance, and UV-visible spectroscopy yield complementary molecular and structural information. Flow cytometry and advanced microscopy enable cellular and morphological interrogation that links material properties to biological responses. The integration of these technologies is increasingly necessary to construct a convergent body of evidence that satisfies multidisciplinary regulatory expectations.

End-user segmentation drives demand characteristics and service-level expectations. Academic institutions and research institutes often prioritize exploratory and mechanistic studies, while contract research organizations support scaled validation studies under regulated conditions. Hospitals and clinical laboratories, including diagnostic centers and specialty clinics, require rapid turnaround and robust clinical relevance. Medical device manufacturers, spanning large original equipment manufacturers and small and medium enterprises, demand both depth and scalability in testing capacity. Device-type segmentation-covering cardiovascular products such as heart valves, pacemakers, and stents, as well as dental, diagnostic imaging, neurological, ophthalmic, and orthopedic devices-further dictates specialized protocols, instrumentation, and clinician-engaged performance endpoints. Taken together, these segmentation layers shape investment priorities for laboratories, influence accreditation and staffing decisions, and determine pathways to achieve regulatory acceptance.

Navigating divergent regional regulatory expectations, laboratory capacities, and supply chain realities to deploy validation strategies that optimize global market access

Regional dynamics create distinct demand profiles, regulatory expectations, and operational constraints that testing strategy must accommodate. In the Americas, a combination of mature regulatory frameworks and a high concentration of device manufacturers drives demand for comprehensive premarket testing and post-market surveillance capabilities. Laboratories in the region often focus on rapid regulatory submissions and integration with clinical study timelines, while supply chain considerations favor near-term inventory and flexible service models to meet tight commercialization schedules.

In Europe, the Middle East & Africa region, regulatory harmonization efforts and the prominence of notified bodies shape a risk-based approach to testing and documentation. The interplay between regional regulatory authorities and local accreditation bodies means that manufacturers must adapt protocols to satisfy both harmonized standards and country-specific requirements. This drives demand for consultative testing partners who can navigate multi-jurisdictional expectations and provide assurance across certification pathways.

The Asia-Pacific region presents a mix of high-volume manufacturing, rapidly modernizing regulatory regimes, and expanding clinical research activity. Laboratories here increasingly invest in advanced analytical platforms and workforce development to support both domestic manufacturers and global supply chains. Differences in accreditation standards, combined with variability in infrastructure maturity across countries, lead manufacturers to adopt hybrid strategies that combine local testing for throughput with regional or global centers of excellence for specialized assays. Recognizing these regional distinctions helps organizations allocate resources and design validation approaches that minimize regulatory friction and optimize time to market across geographies.

How differentiated laboratory capabilities, strategic partnerships, and service integration determine competitive advantage and inform partner selection criteria

Corporate behavior and competitive positioning influence where and how testing capacity expands, and companies differentiate through capability depth, geographic coverage, and integrated service offerings. Tier-one analytical service providers often emphasize end-to-end portfolios that combine chemical characterization, biological evaluation, and sterilization expertise to support comprehensive submissions. These providers invest in high-throughput instrumentation, validated workflows, and quality management systems that appeal to large manufacturers seeking single-vendor accountability.

Meanwhile, specialized laboratories focus on niche capabilities-such as advanced mass spectrometry, immunotoxicology, or combination-product testing-offering deep technical expertise and bespoke method development. These specialists frequently collaborate with manufacturers during design transfer to co-develop assays that anticipate regulatory queries. Contract research organizations and clinical laboratories play a complementary role by enabling scale and clinical integration, particularly when device validation requires patient-derived data or real-world performance metrics.

Emerging competitive dynamics also reflect consolidation, strategic partnerships, and cross-sector collaborations that accelerate capability build-outs. Manufacturers increasingly form long-term partnerships with testing providers to align validation timelines with product roadmaps, embed feedback loops between design and testing teams, and share investment risk in new method validation. This trend highlights the importance of evaluating potential partners not only for technical competence but also for cultural fit, data governance practices, and capacity to support iterative development over the product lifecycle.

Practical actions to integrate testing strategy with design, regulatory engagement, and resilient sourcing to accelerate compliant product development and market entry

Industry leaders should adopt a proactive posture that aligns testing strategy with product development, regulatory engagement, and supply chain resilience. First, embed testing considerations early in product design by applying risk-based frameworks that prioritize assays with the greatest impact on clinical performance and regulatory acceptance. Early alignment reduces late-stage surprises and enables parallel execution of engineering and validation activities, thereby compressing overall timelines.

Second, diversify sourcing and capacity through a blended model that combines in-house capabilities for core competencies with vetted external partners for specialized assays and surge capacity. Establishing clear quality agreements, method transfer protocols, and data standards ensures equivalency and preserves audit readiness when work crosses organizational boundaries. Third, invest in analytics and laboratory information management systems to improve data traceability, automate routine reporting, and support advanced data review. These investments not only improve reproducibility but also facilitate regulatory submissions that increasingly rely on integrated datasets.

Finally, build regulatory engagement into the validation roadmap by initiating early dialogues with assessors, submitting pre-submission data packages where appropriate, and documenting rationale for method selection and acceptance criteria. Complement these activities with workforce development programs that upskill laboratory personnel in contemporary techniques, regulatory expectations, and quality systems. Taken together, these actions fortify an organization's ability to deliver compliant, clinically relevant evidence within compressed commercial timelines.

A rigorous, multi-source research approach combining expert interviews, technical validation, and scenario analysis to produce robust insights for validation strategy and operations

The research underpinning this analysis combined structured primary inquiry with systematic secondary review and technical validation to ensure actionable insight. Primary research included interviews with regulatory experts, senior laboratory managers, quality assurance leaders, and clinical affairs professionals to capture first-hand perspectives on capacity constraints, method development priorities, and regulatory interactions. These conversations provided context for operational realities such as lead times, accreditation challenges, and investment trade-offs.

Secondary research synthesized publicly available regulatory guidance, standards documents, and technology briefs to map the evolving expectations that shape validation protocols. Technical validation exercises reviewed methodological literature and instrument specifications to confirm capability claims and to illustrate where convergent approaches provide stronger evidence. Throughout the research process, triangulation of findings from multiple sources improved robustness and reduced reliance on any single data point.

Analytical methods included scenario analysis to explore tariff impact permutations, gap analyses to identify capability shortfalls across test types and technologies, and stakeholder mapping to highlight critical decision nodes in the validation lifecycle. Quality control measures encompassed peer review by subject-matter experts and iterative refinement based on respondent feedback, ensuring that conclusions reflect both operational practicality and regulatory plausibility.

Consolidated conclusions on the strategic imperative to treat testing as a core competency and align validation with regulatory, technical, and commercial realities

In conclusion, the medical device testing environment is rapidly evolving in response to technological advances, elevated regulatory expectations, and shifting commercial pressures. Organizations that succeed will treat testing as a strategic competency, invest in the right mix of technologies and partnerships, and design validation pathways that anticipate lifecycle evidence requirements. Tariff changes and regional dynamics further complicate the operating picture, underscoring the need for flexible sourcing strategies and regulatory harmonization efforts that reduce friction across borders.

Leaders should prioritize early integration of testing into product development, cultivate partnerships that provide both depth and scalability, and invest in data systems that ensure reproducibility and audit readiness. By doing so, they can shorten time to market, reduce risk, and maintain the credibility of clinical and safety claims. The path forward demands deliberate planning, disciplined execution, and continuous monitoring of regulatory and supply chain developments.

This synthesis provides a foundation for practical decision-making; stakeholders who align these insights with their specific product portfolios and organizational capacities will be better positioned to navigate the complexities of validation and deliver safe, effective devices to the patients who need them.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Medical Device Testing Market, by Service Type

  • 8.1. Biocompatibility Testing
  • 8.2. Mechanical and Physical Testing
  • 8.3. Electrical Safety and Electromagnetic Compatibility
  • 8.4. Sterility and Microbiology Testing
  • 8.5. Packaging and Shelf-Life Testing
  • 8.6. Software and Cybersecurity Testing
  • 8.7. Clinical Performance and Safety Studies
  • 8.8. Chemical Characterization and Material Analysis

9. Medical Device Testing Market, by Device Type

  • 9.1. In Vitro Diagnostic Devices
  • 9.2. Active Implantable Devices
  • 9.3. Non-Active Implantable Devices
  • 9.4. Surgical Instruments and Tools
  • 9.5. Diagnostic Imaging Devices
  • 9.6. Patient Monitoring Devices
  • 9.7. Wearable and Home-Use Devices
  • 9.8. Drug-Device Combination Products
  • 9.9. Dental Devices
  • 9.10. Orthopedic Devices
  • 9.11. Ophthalmic Devices

10. Medical Device Testing Market, by Device Class

  • 10.1. Class I Devices
  • 10.2. Class II Devices
  • 10.3. Class III Devices
  • 10.4. In Vitro Diagnostic Risk Classes

11. Medical Device Testing Market, by Test Phase

  • 11.1. Concept and Feasibility
  • 11.2. Design Verification and Validation
  • 11.3. Preclinical Testing
  • 11.4. Clinical Testing
  • 11.5. Post-Market Surveillance and Revalidation

12. Medical Device Testing Market, by Sourcing Model

  • 12.1. In-House Testing
  • 12.2. Outsourced Testing
  • 12.3. Hybrid Testing Models

13. Medical Device Testing Market, by Testing Method

  • 13.1. In Vitro Methods
  • 13.2. In Vivo Methods

14. Medical Device Testing Market, by End User

  • 14.1. Medical Device Manufacturers
  • 14.2. Contract Research Organizations
  • 14.3. Independent Testing Laboratories
  • 14.4. Hospitals and Clinics
  • 14.5. Academic and Research Institutions

15. Medical Device Testing Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. Medical Device Testing Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Medical Device Testing Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. United States Medical Device Testing Market

19. China Medical Device Testing Market

20. Competitive Landscape

  • 20.1. Market Concentration Analysis, 2025
    • 20.1.1. Concentration Ratio (CR)
    • 20.1.2. Herfindahl Hirschman Index (HHI)
  • 20.2. Recent Developments & Impact Analysis, 2025
  • 20.3. Product Portfolio Analysis, 2025
  • 20.4. Benchmarking Analysis, 2025
  • 20.5. BSI Group UK Limited
  • 20.6. Bureau Veritas SA
  • 20.7. Charles River Laboratories International, Inc.
  • 20.8. CSA Group
  • 20.9. DEKRA SE
  • 20.10. Eurofins Scientific SE
  • 20.11. GE HealthCare Technologies Inc.
  • 20.12. Intertek Group plc
  • 20.13. Labcorp Holdings Inc.
  • 20.14. NSF International
  • 20.15. Societe Generale de Surveillance SA
  • 20.16. Thermo Fisher Scientific Inc.
  • 20.17. TUV SUD AG
  • 20.18. UL LLC
  • 20.19. WuXi AppTec Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MEDICAL DEVICE TESTING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL MEDICAL DEVICE TESTING MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY SERVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY DEVICE CLASS, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY TEST PHASE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY SOURCING MODEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY TESTING METHOD, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. UNITED STATES MEDICAL DEVICE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 15. CHINA MEDICAL DEVICE TESTING MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY BIOCOMPATIBILITY TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY BIOCOMPATIBILITY TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY BIOCOMPATIBILITY TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY MECHANICAL AND PHYSICAL TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY MECHANICAL AND PHYSICAL TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY MECHANICAL AND PHYSICAL TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY ELECTRICAL SAFETY AND ELECTROMAGNETIC COMPATIBILITY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY ELECTRICAL SAFETY AND ELECTROMAGNETIC COMPATIBILITY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY ELECTRICAL SAFETY AND ELECTROMAGNETIC COMPATIBILITY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY STERILITY AND MICROBIOLOGY TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY STERILITY AND MICROBIOLOGY TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY STERILITY AND MICROBIOLOGY TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY PACKAGING AND SHELF-LIFE TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY PACKAGING AND SHELF-LIFE TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY PACKAGING AND SHELF-LIFE TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY SOFTWARE AND CYBERSECURITY TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY SOFTWARE AND CYBERSECURITY TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY SOFTWARE AND CYBERSECURITY TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY CLINICAL PERFORMANCE AND SAFETY STUDIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY CLINICAL PERFORMANCE AND SAFETY STUDIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY CLINICAL PERFORMANCE AND SAFETY STUDIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY CHEMICAL CHARACTERIZATION AND MATERIAL ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY CHEMICAL CHARACTERIZATION AND MATERIAL ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY CHEMICAL CHARACTERIZATION AND MATERIAL ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY IN VITRO DIAGNOSTIC DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY IN VITRO DIAGNOSTIC DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY IN VITRO DIAGNOSTIC DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY ACTIVE IMPLANTABLE DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY ACTIVE IMPLANTABLE DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY ACTIVE IMPLANTABLE DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY NON-ACTIVE IMPLANTABLE DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY NON-ACTIVE IMPLANTABLE DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY NON-ACTIVE IMPLANTABLE DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY SURGICAL INSTRUMENTS AND TOOLS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY SURGICAL INSTRUMENTS AND TOOLS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY SURGICAL INSTRUMENTS AND TOOLS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY DIAGNOSTIC IMAGING DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY DIAGNOSTIC IMAGING DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY DIAGNOSTIC IMAGING DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY PATIENT MONITORING DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY PATIENT MONITORING DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY PATIENT MONITORING DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY WEARABLE AND HOME-USE DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY WEARABLE AND HOME-USE DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY WEARABLE AND HOME-USE DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY DRUG-DEVICE COMBINATION PRODUCTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY DRUG-DEVICE COMBINATION PRODUCTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY DRUG-DEVICE COMBINATION PRODUCTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY DENTAL DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY DENTAL DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY DENTAL DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY ORTHOPEDIC DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY ORTHOPEDIC DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY ORTHOPEDIC DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY OPHTHALMIC DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY OPHTHALMIC DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY OPHTHALMIC DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY DEVICE CLASS, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY CLASS I DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY CLASS I DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY CLASS I DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY CLASS II DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY CLASS II DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY CLASS II DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY CLASS III DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY CLASS III DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY CLASS III DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY IN VITRO DIAGNOSTIC RISK CLASSES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY IN VITRO DIAGNOSTIC RISK CLASSES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY IN VITRO DIAGNOSTIC RISK CLASSES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY TEST PHASE, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY CONCEPT AND FEASIBILITY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY CONCEPT AND FEASIBILITY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY CONCEPT AND FEASIBILITY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY DESIGN VERIFICATION AND VALIDATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY DESIGN VERIFICATION AND VALIDATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY DESIGN VERIFICATION AND VALIDATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY PRECLINICAL TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY PRECLINICAL TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY PRECLINICAL TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY CLINICAL TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY CLINICAL TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY CLINICAL TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY POST-MARKET SURVEILLANCE AND REVALIDATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY POST-MARKET SURVEILLANCE AND REVALIDATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY POST-MARKET SURVEILLANCE AND REVALIDATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY SOURCING MODEL, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY IN-HOUSE TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY IN-HOUSE TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY IN-HOUSE TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY OUTSOURCED TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY OUTSOURCED TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY OUTSOURCED TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY HYBRID TESTING MODELS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY HYBRID TESTING MODELS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY HYBRID TESTING MODELS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY TESTING METHOD, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY IN VITRO METHODS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY IN VITRO METHODS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY IN VITRO METHODS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY IN VIVO METHODS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY IN VIVO METHODS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY IN VIVO METHODS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY MEDICAL DEVICE MANUFACTURERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY MEDICAL DEVICE MANUFACTURERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY MEDICAL DEVICE MANUFACTURERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY INDEPENDENT TESTING LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY INDEPENDENT TESTING LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY INDEPENDENT TESTING LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY HOSPITALS AND CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY HOSPITALS AND CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 124. AMERICAS MEDICAL DEVICE TESTING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 125. AMERICAS MEDICAL DEVICE TESTING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. AMERICAS MEDICAL DEVICE TESTING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. AMERICAS MEDICAL DEVICE TESTING MARKET SIZE, BY DEVICE CLASS, 2018-2032 (USD MILLION)
  • TABLE 128. AMERICAS MEDICAL DEVICE TESTING MARKET SIZE, BY TEST PHASE, 2018-2032 (USD MILLION)
  • TABLE 129. AMERICAS MEDICAL DEVICE TESTING MARKET SIZE, BY SOURCING MODEL, 2018-2032 (USD MILLION)
  • TABLE 130. AMERICAS MEDICAL DEVICE TESTING MARKET SIZE, BY TESTING METHOD, 2018-2032 (USD MILLION)
  • TABLE 131. AMERICAS MEDICAL DEVICE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA MEDICAL DEVICE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA MEDICAL DEVICE TESTING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. NORTH AMERICA MEDICAL DEVICE TESTING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. NORTH AMERICA MEDICAL DEVICE TESTING MARKET SIZE, BY DEVICE CLASS, 2018-2032 (USD MILLION)
  • TABLE 136. NORTH AMERICA MEDICAL DEVICE TESTING MARKET SIZE, BY TEST PHASE, 2018-2032 (USD MILLION)
  • TABLE 137. NORTH AMERICA MEDICAL DEVICE TESTING MARKET SIZE, BY SOURCING MODEL, 2018-2032 (USD MILLION)
  • TABLE 138. NORTH AMERICA MEDICAL DEVICE TESTING MARKET SIZE, BY TESTING METHOD, 2018-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA MEDICAL DEVICE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA MEDICAL DEVICE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA MEDICAL DEVICE TESTING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. LATIN AMERICA MEDICAL DEVICE TESTING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA MEDICAL DEVICE TESTING MARKET SIZE, BY DEVICE CLASS, 2018-2032 (USD MILLION)
  • TABLE 144. LATIN AMERICA MEDICAL DEVICE TESTING MARKET SIZE, BY TEST PHASE, 2018-2032 (USD MILLION)
  • TABLE 145. LATIN AMERICA MEDICAL DEVICE TESTING MARKET SIZE, BY SOURCING MODEL, 2018-2032 (USD MILLION)
  • TABLE 146. LATIN AMERICA MEDICAL DEVICE TESTING MARKET SIZE, BY TESTING METHOD, 2018-2032 (USD MILLION)
  • TABLE 147. LATIN AMERICA MEDICAL DEVICE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICE TESTING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICE TESTING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICE TESTING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICE TESTING MARKET SIZE, BY DEVICE CLASS, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICE TESTING MARKET SIZE, BY TEST PHASE, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICE TESTING MARKET SIZE, BY SOURCING MODEL, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICE TESTING MARKET SIZE, BY TESTING METHOD, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE MEDICAL DEVICE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE MEDICAL DEVICE TESTING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE MEDICAL DEVICE TESTING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE MEDICAL DEVICE TESTING MARKET SIZE, BY DEVICE CLASS, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE MEDICAL DEVICE TESTING MARKET SIZE, BY TEST PHASE, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE MEDICAL DEVICE TESTING MARKET SIZE, BY SOURCING MODEL, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE MEDICAL DEVICE TESTING MARKET SIZE, BY TESTING METHOD, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE MEDICAL DEVICE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 164. MIDDLE EAST MEDICAL DEVICE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST MEDICAL DEVICE TESTING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. MIDDLE EAST MEDICAL DEVICE TESTING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST MEDICAL DEVICE TESTING MARKET SIZE, BY DEVICE CLASS, 2018-2032 (USD MILLION)
  • TABLE 168. MIDDLE EAST MEDICAL DEVICE TESTING MARKET SIZE, BY TEST PHASE, 2018-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST MEDICAL DEVICE TESTING MARKET SIZE, BY SOURCING MODEL, 2018-2032 (USD MILLION)
  • TABLE 170. MIDDLE EAST MEDICAL DEVICE TESTING MARKET SIZE, BY TESTING METHOD, 2018-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST MEDICAL DEVICE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 172. AFRICA MEDICAL DEVICE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 173. AFRICA MEDICAL DEVICE TESTING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. AFRICA MEDICAL DEVICE TESTING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 175. AFRICA MEDICAL DEVICE TESTING MARKET SIZE, BY DEVICE CLASS, 2018-2032 (USD MILLION)
  • TABLE 176. AFRICA MEDICAL DEVICE TESTING MARKET SIZE, BY TEST PHASE, 2018-2032 (USD MILLION)
  • TABLE 177. AFRICA MEDICAL DEVICE TESTING MARKET SIZE, BY SOURCING MODEL, 2018-2032 (USD MILLION)
  • TABLE 178. AFRICA MEDICAL DEVICE TESTING MARKET SIZE, BY TESTING METHOD, 2018-2032 (USD MILLION)
  • TABLE 179. AFRICA MEDICAL DEVICE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 180. ASIA-PACIFIC MEDICAL DEVICE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. ASIA-PACIFIC MEDICAL DEVICE TESTING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. ASIA-PACIFIC MEDICAL DEVICE TESTING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. ASIA-PACIFIC MEDICAL DEVICE TESTING MARKET SIZE, BY DEVICE CLASS, 2018-2032 (USD MILLION)
  • TABLE 184. ASIA-PACIFIC MEDICAL DEVICE TESTING MARKET SIZE, BY TEST PHASE, 2018-2032 (USD MILLION)
  • TABLE 185. ASIA-PACIFIC MEDICAL DEVICE TESTING MARKET SIZE, BY SOURCING MODEL, 2018-2032 (USD MILLION)
  • TABLE 186. ASIA-PACIFIC MEDICAL DEVICE TESTING MARKET SIZE, BY TESTING METHOD, 2018-2032 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC MEDICAL DEVICE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 189. ASEAN MEDICAL DEVICE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. ASEAN MEDICAL DEVICE TESTING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. ASEAN MEDICAL DEVICE TESTING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. ASEAN MEDICAL DEVICE TESTING MARKET SIZE, BY DEVICE CLASS, 2018-2032 (USD MILLION)
  • TABLE 193. ASEAN MEDICAL DEVICE TESTING MARKET SIZE, BY TEST PHASE, 2018-2032 (USD MILLION)
  • TABLE 194. ASEAN MEDICAL DEVICE TESTING MARKET SIZE, BY SOURCING MODEL, 2018-2032 (USD MILLION)
  • TABLE 195. ASEAN MEDICAL DEVICE TESTING MARKET SIZE, BY TESTING METHOD, 2018-2032 (USD MILLION)
  • TABLE 196. ASEAN MEDICAL DEVICE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 197. GCC MEDICAL DEVICE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 198. GCC MEDICAL DEVICE TESTING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 199. GCC MEDICAL DEVICE TESTING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. GCC MEDICAL DEVICE TESTING MARKET SIZE, BY DEVICE CLASS, 2018-2032 (USD MILLION)
  • TABLE 201. GCC MEDICAL DEVICE TESTING MARKET SIZE, BY TEST PHASE, 2018-2032 (USD MILLION)
  • TABLE 202. GCC MEDICAL DEVICE TESTING MARKET SIZE, BY SOURCING MODEL, 2018-2032 (USD MILLION)
  • TABLE 203. GCC MEDICAL DEVICE TESTING MARKET SIZE, BY TESTING METHOD, 2018-2032 (USD MILLION)
  • TABLE 204. GCC MEDICAL DEVICE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPEAN UNION MEDICAL DEVICE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPEAN UNION MEDICAL DEVICE TESTING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPEAN UNION MEDICAL DEVICE TESTING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPEAN UNION MEDICAL DEVICE TESTING MARKET SIZE, BY DEVICE CLASS, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPEAN UNION MEDICAL DEVICE TESTING MARKET SIZE, BY TEST PHASE, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPEAN UNION MEDICAL DEVICE TESTING MARKET SIZE, BY SOURCING MODEL, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPEAN UNION MEDICAL DEVICE TESTING MARKET SIZE, BY TESTING METHOD, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPEAN UNION MEDICAL DEVICE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 213. BRICS MEDICAL DEVICE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 214. BRICS MEDICAL DEVICE TESTING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 215. BRICS MEDICAL DEVICE TESTING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 216. BRICS MEDICAL DEVICE TESTING MARKET SIZE, BY DEVICE CLASS, 2018-2032 (USD MILLION)
  • TABLE 217. BRICS MEDICAL DEVICE TESTING MARKET SIZE, BY TEST PHASE, 2018-2032 (USD MILLION)
  • TABLE 218. BRICS MEDICAL DEVICE TESTING MARKET SIZE, BY SOURCING MODEL, 2018-2032 (USD MILLION)
  • TABLE 219. BRICS MEDICAL DEVICE TESTING MARKET SIZE, BY TESTING METHOD, 2018-2032 (USD MILLION)
  • TABLE 220. BRICS MEDICAL DEVICE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 221. G7 MEDICAL DEVICE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 222. G7 MEDICAL DEVICE TESTING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 223. G7 MEDICAL DEVICE TESTING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 224. G7 MEDICAL DEVICE TESTING MARKET SIZE, BY DEVICE CLASS, 2018-2032 (USD MILLION)
  • TABLE 225. G7 MEDICAL DEVICE TESTING MARKET SIZE, BY TEST PHASE, 2018-2032 (USD MILLION)
  • TABLE 226. G7 MEDICAL DEVICE TESTING MARKET SIZE, BY SOURCING MODEL, 2018-2032 (USD MILLION)
  • TABLE 227. G7 MEDICAL DEVICE TESTING MARKET SIZE, BY TESTING METHOD, 2018-2032 (USD MILLION)
  • TABLE 228. G7 MEDICAL DEVICE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 229. NATO MEDICAL DEVICE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 230. NATO MEDICAL DEVICE TESTING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 231. NATO MEDICAL DEVICE TESTING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 232. NATO MEDICAL DEVICE TESTING MARKET SIZE, BY DEVICE CLASS, 2018-2032 (USD MILLION)
  • TABLE 233. NATO MEDICAL DEVICE TESTING MARKET SIZE, BY TEST PHASE, 2018-2032 (USD MILLION)
  • TABLE 234. NATO MEDICAL DEVICE TESTING MARKET SIZE, BY SOURCING MODEL, 2018-2032 (USD MILLION)
  • TABLE 235. NATO MEDICAL DEVICE TESTING MARKET SIZE, BY TESTING METHOD, 2018-2032 (USD MILLION)
  • TABLE 236. NATO MEDICAL DEVICE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 237. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 238. UNITED STATES MEDICAL DEVICE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 239. UNITED STATES MEDICAL DEVICE TESTING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 240. UNITED STATES MEDICAL DEVICE TESTING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 241. UNITED STATES MEDICAL DEVICE TESTING MARKET SIZE, BY DEVICE CLASS, 2018-2032 (USD MILLION)
  • TABLE 242. UNITED STATES MEDICAL DEVICE TESTING MARKET SIZE, BY TEST PHASE, 2018-2032 (USD MILLION)
  • TABLE 243. UNITED STATES MEDICAL DEVICE TESTING MARKET SIZE, BY SOURCING MODEL, 2018-2032 (USD MILLION)
  • TABLE 244. UNITED STATES MEDICAL DEVICE TESTING MARKET SIZE, BY TESTING METHOD, 2018-2032 (USD MILLION)
  • TABLE 245. UNITED STATES MEDICAL DEVICE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 246. CHINA MEDICAL DEVICE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 247. CHINA MEDICAL DEVICE TESTING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 248. CHINA MEDICAL DEVICE TESTING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 249. CHINA MEDICAL DEVICE TESTING MARKET SIZE, BY DEVICE CLASS, 2018-2032 (USD MILLION)
  • TABLE 250. CHINA MEDICAL DEVICE TESTING MARKET SIZE, BY TEST PHASE, 2018-2032 (USD MILLION)
  • TABLE 251. CHINA MEDICAL DEVICE TESTING MARKET SIZE, BY SOURCING MODEL, 2018-2032 (USD MILLION)
  • TABLE 252. CHINA MEDICAL DEVICE TESTING MARKET SIZE, BY TESTING METHOD, 2018-2032 (USD MILLION)
  • TABLE 253. CHINA MEDICAL DEVICE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)